Medical specialists from Denmark tagged as investigators in clinical trials studying Demyelinating Diseases

Total 3 results

Hartwig R Siebner, Prof
Seen in:
- Hvidovre, Danish Research Centre for Magnetic Resonance
Trials:
- NCT04977622 (Principal Investigator)
Conditions:
- Primary Progressive Multiple Sclerosis
Nasrin Asgari, Prof.
Seen in:
- Odense, Department of Neurology, Slagelse, Institute for Health Research, University of Southern Denmark
Trials:
- NCT05605951 (Principal Investigator)
Conditions:
Vanessa Wiggermann, PhD
Seen in:
- Hvidovre, Danish Research Centre for Magnetic Resonance
Trials:
- NCT04977622 (Principal Investigator)
Conditions:
- Primary Progressive Multiple Sclerosis

Clinical Trials on Demyelinating Diseases

The Hospital for Sick Children

Completed

Pharmacological Recruitment of Endogenous Neural Precursors to Promote Pediatric White Matter Repair: Establishing Correlations Between Visual Outcomes, Saccadic Function and MEG Oscillations in Children With Demyelinating Disorders in Comparison to Healthy Control Children

Demyelinating Disease

Canada
Kristin Zhao, PhD
Mayo Clinic

Recruiting

Epidural Stimulation in Multiple Sclerosis

Multiple Sclerosis | Autoimmune Diseases | Demyelinating Disorder

United States
Centre Hospitalier Universitaire de Saint Etienne
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg (PRNC)

Demyelinating Polyneuropathy

France
Takeda
RTI Health Solutions; Baxalta Innovations GmbH, now part of Shire

Completed

A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

United States
CSL Behring

Completed

Extension Study of Maintenance Treatment With Subcutaneous Immunoglobulin (IgPro20) for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

United States, Japan, Australia, Canada, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
University of Aarhus
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital

Recruiting

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC) (SIDEC)

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Denmark
Vera Bril

Unknown

Panzyga in CIDP Administered at Different Infusion Rates (Panzyga-CIDP)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Canada
UCB Biopharma SRL

Completed

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

United States, Belgium, Denmark, France, Germany, Netherlands, Spain, United Kingdom
Nagoya University
Japan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.

Completed

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies (RECIPE)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Japan
Johns Hopkins University
Genzyme, a Sanofi Company

Withdrawn

Alemtuzumab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIPD)

Chronic Inflammatory Demyelinating Neuropathy

United States

Medical specialists from Denmark tagged as investigators in clinical trials studying Demyelinating Diseases

Clinical Trials on Demyelinating Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations